151 related articles for article (PubMed ID: 34089721)
1. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
[TBL] [Abstract][Full Text] [Related]
2. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
[TBL] [Abstract][Full Text] [Related]
3. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
[TBL] [Abstract][Full Text] [Related]
4. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
5. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
Herman S; Rogers HD; Ratner D
Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine for skin cancer prevention in solid organ transplant recipients.
Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
[TBL] [Abstract][Full Text] [Related]
11. Early Life UV and Risk of Basal and Squamous Cell Carcinoma in New South Wales, Australia.
Kricker A; Weber M; Sitas F; Banks E; Rahman B; Goumas C; Kabir A; Hodgkinson VS; van Kemenade CH; Waterboer T; Armstrong BK
Photochem Photobiol; 2017 Nov; 93(6):1483-1491. PubMed ID: 28710897
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
13. A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions.
Welsh MM; Karagas MR; Applebaum KM; Spencer SK; Perry AE; Nelson HH
Carcinogenesis; 2008 Oct; 29(10):1950-4. PubMed ID: 18641401
[TBL] [Abstract][Full Text] [Related]
14. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
15. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women.
Wu S; Han J; Vleugels RA; Puett R; Laden F; Hunter DJ; Qureshi AA
Br J Cancer; 2014 Apr; 110(7):1855-61. PubMed ID: 24595003
[TBL] [Abstract][Full Text] [Related]
16. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
17. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.
Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT
Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910
[TBL] [Abstract][Full Text] [Related]
18. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
